Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 268407, 10 pages
http://dx.doi.org/10.1155/2013/268407
Research Article

Serum N-Glycan Profiling Predicts Prognosis in Patients Undergoing Hemodialysis

1Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan
2Faculty of Advanced Life Science and Frontier Research Center for Post-Genome Science and Technology, Hokkaido University, Sapporo 001-0021, Japan
3Department of Advanced Transplant and Regenerative Medicine, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan
4Department of Radiological Technology, Hirosaki University School of Health Sciences, Hirosaki 036-8562, Japan
5Department of Urology, Oyokyo Kidney Research Institute, Hirosaki 036-8243, Japan

Received 14 October 2013; Accepted 26 November 2013

Academic Editors: A. R. Nissenson and H. Yamabe

Copyright © 2013 Shingo Hatakeyama et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Levey, J. A. Beto, B. E. Coronado et al., “Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here?” American Journal of Kidney Diseases, vol. 32, no. 5, pp. 853–906, 1998. View at Google Scholar · View at Scopus
  2. M. J. Sarnak, A. S. Levey, A. C. Schoolwerth et al., “Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research,” Hypertension, vol. 42, no. 5, pp. 1050–1065, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. R. N. Foley, P. S. Parfrey, and M. J. Sarnak, “Clinical epidemiology of cardiovascular disease in chronic renal disease,” American Journal of Kidney Diseases, vol. 32, no. 5, pp. S112–S119, 1998. View at Google Scholar · View at Scopus
  4. F. Stam, C. Van Guldener, A. Decker et al., “Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study,” Journal of the American Society of Nephrology, vol. 17, no. 2, pp. 537–545, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. G. Bostom, D. Shemin, P. Verhoef et al., “Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: a prospective study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 11, pp. 2554–2558, 1997. View at Google Scholar · View at Scopus
  6. V. Panichi, G. M. Rizza, S. Paoletti et al., “Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study,” Nephrology Dialysis Transplantation, vol. 23, no. 7, pp. 2337–2343, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Blacher, A. P. Guerin, B. Pannier, S. J. Marchais, and G. M. London, “Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease,” Hypertension, vol. 38, no. 4, pp. 938–942, 2001. View at Google Scholar · View at Scopus
  8. M. Tsushima, Y. Terayama, A. Momose, T. Funyu, C. Ohyama, and R. Hada, “Carotid intima media thickness and aortic calcification index closely relate to cerebro- and cardiovascular disorders in hemodialysis patients,” International Journal of Urology, vol. 15, no. 1, pp. 48–51, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Ishimura, T. Takahashi, H. Nakagawa et al., “N-acetylglucosaminyltransferase V and β1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer,” Clinical Cancer Research, vol. 12, no. 8, pp. 2506–2511, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Hatakeyama, A. Kyan, H. Yamamoto et al., “Core 2 N expression induces aggressive potential of testicular germ cell tumor,” International Journal of Cancer, vol. 127, no. 5, pp. 1052–1059, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Hagisawa, C. Ohyama, T. Takahashi et al., “Expression of core 2 β1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression,” Glycobiology, vol. 15, no. 10, pp. 1016–1024, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. D'Arrigo, C. Belluco, A. Ambrosi et al., “Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma,” International Journal of Cancer, vol. 115, no. 2, pp. 256–262, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Moriwaki, K. Noda, T. Nakagawa et al., “A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation,” Glycobiology, vol. 17, no. 12, pp. 1311–1320, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Okuyama, Y. Ide, M. Nakano et al., “Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation,” International Journal of Cancer, vol. 118, no. 11, pp. 2803–2808, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. M. Oken, R. H. Creech, and T. E. Davis, “Toxicology and response criteria of the Eastern Cooperative Oncology Group,” American Journal of Clinical Oncology, vol. 5, no. 6, pp. 649–655, 1982. View at Google Scholar · View at Scopus
  16. S.-I. Nishimura, “Toward automated glycan analysis,” Advances in Carbohydrate Chemistry and Biochemistry, vol. 65, pp. 219–271, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. K. Akobeng, “Understanding diagnostic tests 3: receiver operating characteristic curves,” Acta Paediatrica, International Journal of Paediatrics, vol. 96, no. 5, pp. 644–647, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S.-I. Hakomori, “Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines,” Advances in Experimental Medicine and Biology, vol. 491, pp. 369–402, 2001. View at Google Scholar · View at Scopus
  19. K. Nouso, M. Amano, Y. M. Ito et al., “Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer,” Journal of Gastroenterology, vol. 48, no. 10, pp. 1171–1179, 2013. View at Publisher · View at Google Scholar
  20. W. R. Alley, M. Madera, Y. Mechref, and M. V. Novotny, “Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N glycans: a potential methodology for cancer-biomarker discovery,” Analytical Chemistry, vol. 82, no. 12, pp. 5095–5106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Bones, J. C. Byrne, N. Odonoghue et al., “Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms,” Journal of Proteome Research, vol. 10, no. 3, pp. 1246–1265, 2011. View at Publisher · View at Google Scholar · View at Scopus